An open label, prospective, randomized, controlled, multicenter study assessing fixed dose vs. concentration controlled CellCept [mycophenolate mofetil] regimens for patients following a single organ renal tranplantation in combination with full dose and reduced dose calcineurin inhibitors

Trial Profile

An open label, prospective, randomized, controlled, multicenter study assessing fixed dose vs. concentration controlled CellCept [mycophenolate mofetil] regimens for patients following a single organ renal tranplantation in combination with full dose and reduced dose calcineurin inhibitors

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2010

At a glance

  • Drugs Ciclosporin; Corticosteroids; Mycophenolate mofetil; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Actual initiation date (Jan 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top